Laletin V, Bernard P, Montersino C, Yamanashi Y, Olive D, Castellano R
Sci Rep. 2024; 14(1):15053.
PMID: 38956389
PMC: 11220026.
DOI: 10.1038/s41598-024-66075-0.
Villamar-Cruz O, Loza-Mejia M, Vivar-Sierra A, Saldivar-Ceron H, Patino-Lopez G, Olguin J
Mol Cell Biol. 2023; 43(12):631-649.
PMID: 38014992
PMC: 10761042.
DOI: 10.1080/10985549.2023.2273193.
Ogura M, Kaminishi T, Shima T, Torigata M, Bekku N, Tabata K
EMBO Rep. 2023; 24(12):e57300.
PMID: 37987447
PMC: 10702834.
DOI: 10.15252/embr.202357300.
Huang Y, Crick H, Chaytow H, van der Hoorn D, Alhindi A, Jones R
Mol Ther Nucleic Acids. 2023; 33:617-628.
PMID: 37637210
PMC: 10457688.
DOI: 10.1016/j.omtn.2023.07.036.
Goel R, Kim N, Lukong K
Heliyon. 2023; 9(6):e16421.
PMID: 37251450
PMC: 10220380.
DOI: 10.1016/j.heliyon.2023.e16421.
Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors.
Guan Y, Li M, Qiu Z, Xu J, Zhang Y, Hu N
J Adv Res. 2022; 36:73-87.
PMID: 35127166
PMC: 8799871.
DOI: 10.1016/j.jare.2021.06.008.
Bottom-up reconstitution of focal adhesion complexes.
Schumacher S, Vazquez Nunez R, Biertumpfel C, Mizuno N
FEBS J. 2021; 289(12):3360-3373.
PMID: 33999507
PMC: 9290908.
DOI: 10.1111/febs.16023.
DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway.
Yue C, Bai Y, Piao Y, Liu H
J Oncol. 2021; 2021:4035257.
PMID: 33552156
PMC: 7847321.
DOI: 10.1155/2021/4035257.
CD200-CD200R signaling and diseases: a potential therapeutic target?.
Ngwa C, Liu F
Int J Physiol Pathophysiol Pharmacol. 2020; 11(6):297-309.
PMID: 31993106
PMC: 6971504.
Nck adapter proteins promote podosome biogenesis facilitating extracellular matrix degradation and cancer invasion.
Chaki S, Barhoumi R, Rivera G
Cancer Med. 2019; 8(17):7385-7398.
PMID: 31638742
PMC: 6885876.
DOI: 10.1002/cam4.2640.
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun G, Tang L, Zhou J, Xu Z, Yang L, Yuan Q
Cancer Med. 2019; 8(14):6393-6402.
PMID: 31486300
PMC: 6797566.
DOI: 10.1002/cam4.2540.
Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During Phagocytosis by Human Mononuclear Phagocytes.
Hoang K, Rajaram M, Curry H, Gavrilin M, Wewers M, Schlesinger L
Front Immunol. 2018; 9:561.
PMID: 29632532
PMC: 5879101.
DOI: 10.3389/fimmu.2018.00561.
Phosphorylation site dynamics of early T-cell receptor signaling.
Chylek L, Akimov V, Dengjel J, Rigbolt K, Hu B, Hlavacek W
PLoS One. 2014; 9(8):e104240.
PMID: 25147952
PMC: 4141737.
DOI: 10.1371/journal.pone.0104240.
Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.
Ng K, Yin T, Machida K, Wu Y, Mayer B
Oncogene. 2014; 34(20):2650-9.
PMID: 25043303
PMC: 4302068.
DOI: 10.1038/onc.2014.210.
mRNA expression of DOK1-6 in human breast cancer.
Ghanem T, Bracken J, Kasem A, Jiang W, Mokbel K
World J Clin Oncol. 2014; 5(2):156-63.
PMID: 24829863
PMC: 4014788.
DOI: 10.5306/wjco.v5.i2.156.
BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S, Goel R, Dai C, Kalra N, Beaton-Brown E, Bagu E
PLoS One. 2014; 9(2):e87684.
PMID: 24523872
PMC: 3921129.
DOI: 10.1371/journal.pone.0087684.
Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications.
Kim T, Kim M, Jo S, Park J, Ahn Y
Yonsei Med J. 2013; 54(3):545-59.
PMID: 23549795
PMC: 3635639.
DOI: 10.3349/ymj.2013.54.3.545.
The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
Waterman P, Marschner S, Brandl E, Cambier J
Immunol Lett. 2012; 143(1):122-30.
PMID: 22370159
PMC: 3314150.
DOI: 10.1016/j.imlet.2012.02.009.
The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.
Liu B, Shah E, Jablonowski K, Stergachis A, Engelmann B, Nash P
Sci Signal. 2011; 4(202):ra83.
PMID: 22155787
PMC: 4255630.
DOI: 10.1126/scisignal.2002105.
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
Mercier P, Bachvarova M, Plante M, Gregoire J, Renaud M, Ghani K
Mol Oncol. 2011; 5(5):438-53.
PMID: 21856257
PMC: 5528302.
DOI: 10.1016/j.molonc.2011.07.003.